COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,831 Articles (22,553 medRxiv, 8,278 bioRxiv)

Most recent first Previous |  Page 1959: Articles 19581-19590  | Next

Exploring drugs and vaccines associated with altered risks and severity of COVID-19: a UK Biobank cohort study of all ATC level-4 drug categories
XIANG, Y., WONG, K. C.-Y., SO, H.-C.
10.1101/2020.12.05.20244426 — Posted: 2020-12-07
Antibiotic prescriptions in children with COVID-19 and Multisystem Inflammatory Syndrome: a multinational experience in 990 cases from Latin America
Yock, A., Lenzi, J., Ulloa-Gutierrez, R., Gomez-Vargas, J., Antunez-Montes, O., Rios Aida, J. A., del Aguila, O., Arteaga-Menchaca, E., Campos, F., Uribe, F., Parra Buitrago, A., Betancur Londono, L. M., Brizuela, M., Buonsenso, D.
10.1101/2020.12.05.20243568 — Posted: 2020-12-07
Association of COVID-19 spread with on-demand testing
Robertson, L. S., Robertson, L. S.
10.1101/2020.12.04.20244079 — Posted: 2020-12-07
Multifaceted strategies for the control of COVID-19 outbreaks in long-term care facilities in Ontario, Canada
Vilches, T. N., Nourbakhsh, S., Zhang, K., Juden-Kelly, L., Cipriano, L. E., Langley, J. M., Sah, P., Galvani, A. P., Moghadas, S. M.
10.1101/2020.12.04.20244194 — Posted: 2020-12-07
Synthetic Data Generation for Improved COVID-19 Epidemic Forecasting
Bannur, N., Shah, V., Raval, A., White, J.
10.1101/2020.12.04.20243956 — Posted: 2020-12-07
N95 Filtering Facepiece Respirators Remain Effective After Extensive Reuse During the COVID-19 Pandemic.
Fabre, V., Cosgrove, S. E., Hsu, Y.-J., Jones, G., Helsel, T., Bukowski, J., Sobota, M., Sick-Samuels, A., Milstone, A., Maragakis, L., Rock, C.
10.1101/2020.12.04.20244087 — Posted: 2020-12-07
On the Effects of Misclassification in Estimating Efficacy With Application to Recent COVID-19 Vaccine Trials
Buonaccorsi, J. P.
10.1101/2020.12.04.20244244 — Posted: 2020-12-07
Predicting Hospital Utilization and Inpatient Mortality of Patients Tested for COVID-19
Davis, C., Gao, M., Nichols, M., Henao, R.
10.1101/2020.12.04.20244137 — Posted: 2020-12-07
Lipid storm within the lungs of severe COVID-19 patients: Extensive levels of cyclooxygenase and lipoxygenase-derived inflammatory metabolites.
Archambault, A.-S., Zaid, Y., Rakotoarivelo, V., Dore, E., Dubuc, I., Martin, C., Amar, Y., Cheikh, A., Fares, H., El Hassani, A., Tijani, Y., Laviolette, M., Boilard, E., Flamand, L., Flamand, N.
10.1101/2020.12.04.20242115 — Posted: 2020-12-07 Discussion: Onsite
Decontamination of Common Healthcare Facility Surfaces Contaminated with SARS-CoV-2 using Peracetic Acid Dry Fogging
Cutts, T., Kasloff, S., Safronetz, D., Krishnan, J.
10.1101/2020.12.04.412585 — Posted: 2020-12-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).